medigraphic.com
ISSN 0210-5187 (Electronic)

2006, Number 1

<< Back Next >>

Med Cutan Iber Lat Am 2006; 34 (1)

Topical steroids. Un update

Serrano GP

Language: Spanish
References: 40
Page: 33-38
PDF size: 153.54 Kb.


ABSTRACT

Topical steroids are still an elective treatment for some cutaneous disorders as eccema in children. Topical steroids belongs from the hidrocortison molecule that has been modified by halogenization or sterification in order to encrease their solubility and their antiinflammatory and immunosupresive potencial as well as to decrease their mineralocorticoid and antiproliferative effects.
To choose of the best topical steroid we should consider their therapeutic potencial, the formulation, the extension of the disorder, the type of the lesion, the localization (folders) and the age of the patient, in order to avoid secondary effects and improve their benefits.
Topical steroids are formulate usually associated to antibiotics, urea, salicilic acid, D vitamin derivates depending of the disorder to be treated.


REFERENCES

  1. Ballona R, Ballona C. Corticoides tópicos en pediatría: una puesta al día. Dermatol Peruana. 2003;13:163-70.

  2. Ribera M, Casanova JM. Actualización sobre corticoterapia tópica en dermatología. Formación médica continua. 1998;5:258-65.

  3. Mori M, Pimpinelli N, Gianotti B. Topical corticosteroids and unwanted local effects: improving the benefit/risk ratio. Drug Saf . 1994;10:406-12.

  4. Turpeinen M. Influence of age and severity of dermatitis in the percutaneous absorption of hydrocortisone in children. Br J Dermatol. 1988;118:517-22.

  5. Sharon S, Raimer M D. The safe use of topical corticosteroids in children. Pediatr Ann. 2001;30:225-29.

  6. Maibach H I, Stoughton R B. Topical corticosteroids. Med Clinics of N Am. 1973; 57.

  7. Barnes P J. Anti-inflamatory actions of glucocorticoids: molecular mechanisms. Clin Sci.1998;94:557-72.

  8. Robert N. Mechanisms of glucocorticoids action; what is important?. Thorax. 2000; 55:603-13.

  9. Giménez A M. Corticoides tópicos (I): desarrollo, mecanismo de acción, farmacología. Act Dermatol. 1997;7:495-508.

  10. Goa K L. Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. Drugs. 1988;36 (Suppl. 5):51-61.

  11. Dunkel F G, Elsner P, Burg G. Contact allergies to topical corticosteroids: 10 cases of contact dermatitis. Contact Dermatitis.1991;25:97-103.

  12. Wilkinson S M, Cartwright P H. Hydrocortisone: and important cutaneous allergen. Lancet. 1991;337:761-2.

  13. Dooms-Goossens A, Meinardi M M., Bos J D, Degreef H. Contact allergy to corticosteroids: the results of a two centre study. Br J Dermatol. 1994;130:42-7

  14. Dooms-Goossens A, Verschaeve H, Degreef H, Van Berendoncks J. Contact allergy to hydrocortisone and tixocortol pivalate: problems in the detection of corticosteroid sensitivity. Contact Dermatitis. 1986;14:94-102.

  15. Piracicini B M, Bardaazi F, Morelli R, Tosti A . Contact dermatitis due to budesonide. Contact Dermatitis. 1991;24:54-55.

  16. Brambilla L, Boneschi V, Chiappino G, Fossati S, Pigatto P D. Allergic reactions to topical desoxymethasone and oral triamcinolone. Contact Dermatitis. 1989; 21:272-74.

  17. Camarasa J G, Malet A, Serra E, Lluch M. Contact allergy to toxicortol pivalate. Contact Dermatitis. 1988;21:272-74.

  18. Dooms-Goossens A. Clinical aspects of contact allergy to corticosteroids. Dermatology. 1995;191:109-14.

  19. Boujnah-Khoudja A, Brandle I, Reuter G, Foussereau J . Allergy to 2 new corticoid molecules. Contact Dermatitis. 1984;11: 83-87.

  20. Dooms-Goossens A, Degreef H J, Marien K J C, Coopman S A. Contact allergy to corticosteroids: a frequently missed diagnosis? J Am Acad Dermatol. 1989;21: 538-43.

  21. Lauerma A L, Rasenan L, Reunala T., Reitamo S. Langerhans cells but not monocytes are capable of antigen presentation in vitro in corticosteroid contact hypersensivity. Br J Dermatol. 1990;123:699-705.

  22. Wilkinson S M, Heagrty A H M. Prospective study into the value of patch and intradermal tests in identifying topical corticosteroid allergy. Br J Dermatol. 1992;127:22-25.

  23. Dooms-Goossens A, Morren M. Results of routine patch testing with corticosteroids series in 2073 patients. Contact Dermatitis. 1992;26:182-91.

  24. Reitamo S, Lauerma A L, Förström L. Detection of contact hypersensitivity to topical corticosteroids with hydrocortisone-17 butyrate. Contact Dermatitis. 1989;21: 159-65.

  25. Wilkinson M, Cartwritgh P. The significance of toxicortol pivalate positive tests in leg ulcer patients. Contact Dermatitis. 1988;19:145-46.

  26. Wilkinson S M. Hydrocortisone sensitivity. Clinical features of fifty-nine cases. J Am Acad Dermatol. 1992;27:683-87.

  27. Nakajima H, Mahri S, Nagai R. A case of contact dermatitis due to betamethasone valerate. J Dermatol. 1986;13:467-70.

  28. Feldman S B, Sexton F. M., Buzas J, Marks J G . Allergic contact dermatitis from topical steroids. Contact Dermatitis. 1988;19:226-28.

  29. Goossens A, Matura M, Degeef H. Some new aspects regarding cross-sensitivity. Cutis. 2000;65:43-45.

  30. Coopman S, Dooms-Goossens A. Cross-reactions in topical corticosteroid contact dermatitis. Contact Dermatitis.1988;19: 145-46.

  31. Coopman S, Degreef H, Dooms-Goossens A. Identification of cross-reaction paterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol. 1989;121: 27-34.

  32. Rasmussen J E. Percutaneous absorption of topically applied triamcinolone in children. Arch Dermatol. 1978;114:1165-67.

  33. Crespi H G. Topical corticosteroid therapy for children: alclometasone dipropionate cream 0’05%. Clin Ther. 1986;8:203-10.

  34. Optimum use of topical corticosteroids. Drugs Ther Perspect. 1993;1:8-10.

  35. Gianotti B. Current treatment guidelines for topical corticosteroids. Drugs 1988;36 (Suppl. 5):9-14.

  36. Gianotti B. Topical corticosteroids. Drugs. 1992;44:65-71.

  37. Ortonne J P. Clinical potential of topical corticosteroids. Drugs.1988;36(Suppl. 5): 38-42.

  38. Ramsay C A, Savoie L M, Gilbert M. The treatment of atopic dermatitis with topical fusidic acid and hydrocortisone acetate. J Eur Acad Dermatol Venereol. 1996;7 (Suppl. 1):5-22.

  39. Poyner T F, Dass B K. Comparative efficacy and tolerability of fusidic acid/hydrocortisone cream (Fucidin H cream) and miconazole/hydrocortisone cream ( Daktacort cream) in infected eczema. J Eur acad Dermatol Venereol. 1996; 7(Suppl. 1):23-30.

  40. Wilkinson J D. Fusidic acid in dermatology. Br J Dermatol. 1998;139:37-40.




2020     |     www.medigraphic.com